LFA
CSCI

Lighthouse Financial Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Lighthouse Financial Advisors’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6
Closed – – 284
2019
Q4 		$0 Buy
+6
New +$559 ﹤0.01% 288

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Lighthouse Financial Advisors's CSCI Position: Q1 2020 in Review

Lighthouse Financial Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2020, closing a stake of 6 shares.

Lighthouse Financial Advisors first reported a position in CSCI in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 17 funds tracked by Wall St. Rank hold CSCI as of Q1 2020.

  • Lighthouse Financial Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Lighthouse Financial Advisors sold 6 COSCIENS Biopharma Inc. Common Stock shares in Q1 2020.
  • Lighthouse Financial Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Lighthouse Financial Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $0 in Q4 2019.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2020.

Based on Lighthouse Financial Advisors's 13F filing for Q1 2020, filed 8 May 2020.